Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating lung deposition rate and distribution of tiotropium delivered by HandiHaler in healthy subjects and COPD patients. …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.
Completed trial evaluating the impact of tiotropium (Spiriva) on health-related quality of life in chronic obstructive pulmonary disease pat…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Clinical trial update on a Phase 3 study evaluating tiotropium's effect on exercise tolerance in patients with chronic obstructive pulmonary…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial evaluated the efficacy and safety of tiotropium and ipratropium (Atrovent) in subjects with chronic obstructive pul…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial comparing tiotropium inhalation capsules, salmeterol inhalation aerosol, and placebo in patients with chronic obstr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
This update notes that a clinical trial evaluating Spiriva (tiotropium) in chronic obstructive pulmonary disease has completed. The snippet …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation
Clinical trial evaluating the effect of Spiriva (tiotropium) 18 mcg on health-related quality of life and physical functioning in COPD with …
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Non-invasive Mechanical Ventilation as a Rescue Therapy to Relieve Dyspnea in Patients With Stable Severe COPD [NA]
This completed trial evaluates non-invasive mechanical ventilation as a rescue therapy to relieve dyspnea in patients with stable severe COP…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation [Phase 4]
A Phase 4 study evaluating tiotropium inhalation capsules for exercise tolerance and dyspnea in COPD patients undergoing pulmonary rehabilit…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
A Phase 2 dose-ranging study evaluating Ba 679 BR inhalation powder in patients with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD) [Phase 3]
A Phase 3 pharmacokinetic study in elderly patients with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial comparing tiotropium delivery by HandiHaler versus Respimat in chronic obstructive pulmonary disease; results have been posted…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease
An AstraZeneca-sponsored investigation into health care for primary care patients with chronic obstructive pulmonary disease over the past 1…
-
CLINICAL_TRIALS trial_result · 2014-06-17Clinical Trial Update: 12 / 48 wk Pivotal PFT vs PBO in COPD II [Phase 3]
Boehringer Ingelheim conducted a pivotal Phase 3 trial comparing PFT to placebo in chronic obstructive pulmonary disease. The results were p…
-
CLINICAL_TRIALS trial_result · 2014-06-16Clinical Trial Update: Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II [Phase 3]
Phase 3 trial evaluating the safety and efficacy of BI 1744 CL in chronic obstructive pulmonary disease has completed, with results posted o…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
The update concerns a Phase 3 trial assessing erdosteine for chronic obstructive pulmonary disease. No results are reported and the trial st…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD [Phase 2]
This phase 2 study reports the efficacy and safety of a 4-week inhaled BI 1744 CL treatment in Japanese patients with chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Relative Bioavailability of Olodaterol and Fluconazole [Phase 1]
A Phase 1 study evaluating the pharmacokinetic interaction and relative bioavailability of olodaterol and fluconazole in healthy subjects an…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I [Phase 3]
Phase 3 trial evaluated BI 1744 CL in chronic obstructive pulmonary disease and has completed with results posted. The study assessed safety…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD [Phase 3]
Phase 3 trial comparing umeclidinium/vilanterol to tiotropium in COPD over 24 weeks; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Dietary Nitrate in COPD [NA]
A completed clinical trial in chronic obstructive pulmonary disease evaluating dietary nitrate as an intervention.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. [Phase 2]
This Phase 2 trial evaluates 4 weeks of inhaled BI 1744 CL in patients with chronic obstructive pulmonary disease, reporting on efficacy and…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis [Phase 2]
Phase 2 trial sponsored by PharmaKing evaluating efficacy for acute exacerbations of chronic bronchitis and for chronic bronchitis has compl…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD [Phase 2]
Phase 2 trial evaluating the efficacy and safety of adding a steroid to a regimen of salmeterol and tiotropium in chronic obstructive pulmon…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing umeclidinium bromide/vilanterol to fluticasone propionate/salmeterol in COPD over 12 weeks assessing efficacy and …